Chronic obstructive pulmonary disease, anxiety, and depression: State of the science

Heart and Lung: Journal of Acute and Critical Care

Volumn 38, Issue 1, 2009, Pages 34-47

  Putman Casdorph, Heidi ^a   McCrone, Susan ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUOXETINE; GLUCOCORTICOID; LONG ACTING DRUG; NORTRIPTYLINE; PAROXETINE; SERTRALINE; SHORT ACTING DRUG; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

AMNESIA; ANXIETY; ANXIETY DISORDER; BIBLIOGRAPHIC DATABASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEAR; FUNCTIONAL STATUS; HIGH RISK POPULATION; HUMAN; IRRITABILITY; MANIA; MASS SCREENING; MENTAL DISEASE; MENTAL HEALTH CARE; MOOD CHANGE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; PSYCHOTHERAPY; PULMONARY REHABILITATION; QUALITY OF LIFE; RATING SCALE; RESTLESSNESS; REVIEW; RISK FACTOR; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANXIETY; DEPRESSION; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE; UNITED STATES;

EID: 58149502101     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2008.02.005     Document Type: Review

References (71)

1. Kunik M.E., Roundy K., Veazey C., et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 127 (2005) 1205-1211
2. Chronic Obstructive Pulmonary Disease Fact Sheet (August 2006), American Lung Association. www.lungusa.org Accessed March 8, 2007
3. COPD International. www.copd-international.com Accessed July 4, 2007
4. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 174 (2007) 532-555
5. Han M.K., Postma D., Mannino D.M., et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 176 (2007) 1179-1184
6. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist A.S., and Mannino D.M. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28 (2006) 523-532
7. O'Neill E.S. Illness representation and coping of women with chronic obstructive pulmonary disease: a pilot study. Heart Lung 31 (2002) 295-302
8. Yellowlees P.M., Alpers J.H., Bowden J.J., Bryant G.D., and Ruffin R.E. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 146 (1987) 305-307
9. Brenes G.A. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 65 (2003) 963-970
10. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS Task Force. Eur Respir J 23 (2004) 932-946
11. Physician's desk reference (2007), Thomson Healthcare, Montvale, NJ 61
12. Brown E.S., and Chandler P.A. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 3 (2001) 17-21
13. Foster J.M., Aucott L., van der Werf R.H., et al. High patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross- sectional analysis. Respir Med 100 (2006) 1318-1336
14. Beck A.T., Emery G., and Greenberg R. Anxiety disorders and phobias: a cognitive perspective (2005), Basic Books, New York, NY
15. Spielberger C.D. Theory and research on anxiety (1966), New York, Academic Press
16. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
17. McNair D.M., and Lorr M. An analysis of mood in neurotics. J Abn Soc Psychol 69 (1964) 620-627
18. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psych Meas 1 (1977) 385-401
19. Zigmond A.S., and Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67 (1983) 361-370
20. Beck A.T. A systematic investigation of depression. Compr Psychiatry 2 (1961) 163-170
21. Aghanwa H.S., and Erhabor G.E. Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. J Psychosom Res 50 (2001) 179-183
22. Dowson C., Laing R., Barraclough R., et al. The use of the Hospital Anxiety and Depression scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J 114 (2001) 447-449
23. Guell R., Resqueti V., Sangenis M., et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 129 (2006) 899-904
24. Karajgi B., Rifkin A., Doddi S., and Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 147 (1990) 200-201
25. Porzelius J., Vest M., and Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther 30 (1992) 75-77
26. Gift A.G., Moore T., and Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res 41 (1992) 242-246
27. Beekman A.T., Copeland J.R., and Prince M.J. Review of community prevalence of depression in later life. Br J Psychiatry 174 (1999) 307-311
28. Light R.W., Merrill E.J., Despars J.A., Gordon G.H., and Mutalipassi L.R. Prevalence of depression and anxiety in patients with COPD. Chest 87 (1985) 35-38
29. Borson S., Claypoole K., and McDonald G. Depression and chronic obstructive pulmonary disease: treatment trials. Semin Clin Neuropsychiatry 3 (1998) 115-130
30. Yohannes A.M., Baldwin R.C., and Connolly M.J. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence and validation of the BASDEC screening questionnaire. Int J Psychiatry 15 (2000) 1090-1096
31. Lenfant C. Medical and psychiatric illness: different but concurrent!. Metabolism 54 (2005) 53-54
32. Kunik M., Azzam P., Souchek J., et al. A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics 48 (2007) 16-21
33. Roundy K., Cully J., Stanley M., et al. Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease?. A chart review. J Clin Psychiatry 7 (2005) 213-220
34. Ng T.P., Niti M., Tan W.C., Cao Z., Ong K.C., and Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission symptom burden, functional status, and quality of life. Arch Intern Med 167 (2007) 60-67
35. Weaver T.E., and Narsavage G.L. Physiological variables related to functional status in chronic obstructive pulmonary disease. Nurs Res 41 (1992) 286-291
36. Weaver T.E., Richmond T.S., and Narsavage G.L. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res 46 (1997) 26-31
37. Ormel J., Kempen G., Deeg D., Brilman E., Sondersen E., and Relyveld J. Functioning, well-being, and health perception in late middle-age and older people: comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc 46 (1998) 39-48
38. Koenig H.G., and Kuchibhatla M. Use of health services by hospitalized medically ill depressed elderly patients. Am J Psychiatry 155 (1998) 871-877
39. Seung-Kim H.F., Kunik M.E., Molinari V.A., et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 41 (2000) 465-471
40. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
41. Van Manen J.G., Bindels P.J.E., Ijzermans C.J., van der Zee J.S., Bottems B.J.A.M., and Schade E. Prevalence of comorbidity inpatients with chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 54 (2001) 287-293
42. Stage K.B., Middleboe T., and Pisinger C. Depression and chronic obstructive pulmonary disease (COPD). Impact on survival. Acta Psychiatr Scand 111 (2005) 320-323
43. Borson S., McDonald G.J., Gayle T., Deffebach M., Lakshminarayan S., and VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33 (1992) 190-201
44. Argyropoulou P., Patakas D., Koukou A., Vasiliadis P., and Georgopoulos D. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 60 (1993) 216-220
45. Evans M., Hammond M., Wilson K., Lye M., and Copeland J. Placebo controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 12 (1997) 817-824
46. Smoller J.W., Pollack M.H., Systrom D., and Kradin R.L. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 39 (1998) 24-29
47. Yohannes A.M., Connolly M.J., and Baldwin R.C. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Psychiatry 16 (2001) 451-454
48. Lacasse Y., Beaudoin L., Rousseau L., and Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 61 (2004) 140-147
49. Eiser N., Harte R., Karvounis S., Phillips C., and Isaac M. Effect of treating depression on quality of life and exercise tolerance in severe COPD. COPD 2 (2005) 233-241
50. Singh N.P., Despars J.A., Stansbury D.W., Avalos K., and Light R.W. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 103 (1993) 800-804
51. Papp L.A., Weiss J.R., Greenberg H.E., et al. Sertraline for chronic obstructive pulmonary disease and co-morbid anxiety and mood disorders (Letter to the Editor). Am J Psychiatry 152 (1995) 1531
52. Raji M.A. On depression, antidepressant medications, and resuscitation preferences in COPD patients. Chest 129 (2006) 211
53. Tashkin D., Kanner R., Bailey W., et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet 357 (2001) 1571-1575
54. Versiani M., Moreno R., Ramakers-van Moorsel C.J., et al. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. CNS Drugs 19 (2005) 137-146
55. Emery C.F., Schein R.L., Hauck E.R., and MacIntyre N.R. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. J Health Psychol 17 (1998) 232-240
56. Kunik M.E., Braun U., Stanley M.A., et al. One session cognitive behavioral therapy for elderly patients with chronic pulmonary disease. Psychol Med 31 (2001) 717-723
57. de Godoy D., and de Godoy R. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 84 (2003) 1154-1157
58. Lisansky D., and Hendel-Clough D. A cognitive-behavioral self-help educational program for patients with COPD: a pilot study. Psychother Psychosom 65 (1996) 97-101
59. Eiser N., West C., Evans S., Jeffers A., and Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J 10 (1997) 1581-1584
60. Alexopoulos G.S., Sirey J.A., Raue P.J., Kanellopoulos D., Clark T.E., and Novitch R. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry 14 (2006) 466-475
61. Sassi-Dambron D.E., Eakin E.G., Ries A.L., and Kaplan R.M. Treatment of dyspnea in COPD: a controlled clinical trial of dyspnea management strategies. Chest 107 (1995) 724-729
62. Ries A.L., Kaplan R.M., Limberg T.M., and Prewitt L.M. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 122 (1995) 823-832
63. Withers N.J., Rudkin S.T., and White R.J. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil 19 (1999) 362-365
64. Kozora E., Tran Z.V., and Make B. Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulmon Rehabil 22 (2002) 426-430
65. Nguyen H.Q., and Carrieri-Kohlman V. Dyspnea self-management in patients with chronic obstructive pulmonary disease: moderating effects of depressed mood. Psychosomatics 46 (2005) 402-410
66. Kayahan B., Karapolat H., Atyntoprak E., Atasever A., and Ozturk O. Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med 100 (2006) 1050-1057
67. Derogatis L.R., Yevzeroff H., and Wittelsberger B. Social class, psychological disorder and the nature of the psychopathological indicator. J Consult Clin Psychol 43 (1975) 183-191
68. Paz-Diaz H., de Oca M., Lopez J., and Celli B. Pulmonary rehabilitation improves depression, anxiety, dyspnea, and health status in patients with COPD. Am J Phys Med Rehabil 86 (2006) 30-36
69. Rost K., Nutting P., Smith J.L., Elliot C.E., and Dickinson M. Managing depression as a chronic disease: a randomized trial of ongoing treatment in primary care. BMJ 325 (2002) 934-937
70. Unutzer J., Katon W., Callahan C.M., et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 288 (2002) 2836-2845
71. McGeoch G., Willsman K., Dowson C., Town G., Frampton C., and McCartin F. Self management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology 11 (2006) 611-618